Cc1cc(C)cc(NC(=O)Cn2cc(S(=O)(=O)NC(C)(C)C)c(S(=O)(=O)NC(C)(C)C)c2)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?